Significant Ownership of Sands Capital Alternatives, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Sands Capital Alternatives, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jonathan Goodman - Jonathan Goodman, General Counsel
- Manager location
- Arlington, VA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Sands Capital Alternatives, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Sands Capital Alternatives, LLC
Significant Ownership of Sands Capital Alternatives, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 5.6% | $3,861,295 | 3,417,075 | Sands Capital Alternatives, LLC | 30 Jun 2025 | ||
| KVYO | Klaviyo, Inc. | Series A Common Stock, par value $0.001 per share | 4.9% | $127,806,680 | 4,416,264 | SANDS FRANK M. | 31 Mar 2025 |
Schedules 13D/G Reported by Sands Capital Alternatives, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.